Prices are updated after-hours

TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVJF | News | $12.37 -24.22% 380

(0.0% 1d) (0.0% 1m) (48.1% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (83.09% volume)
Earnings Calendar:
Market Cap: $ 14,739,472,016
http://www.teva.co.il
Sec Filling | Patents | n/a employees

(IL) Teva Pharmaceutical Industries Ltd. engages in the development and production of medicines. Its products include medicines for cardiovascular diseases, pain relievers, obesity, cancer and supportive care, infectious diseases and human immunodeficiency viruses, and colds and coughs. The company was founded in 1901 and is headquartered in Petah Tikva, Israel.

cancer infectious disease pain relief israel cardiovascular

add to watch list Paper trade email alert is off

Kratos Defense & Security Solutions, Inc.

KTOS S | $18.02 2.33% 2.28% 1.2M

Electronic Technology

(0.0% 1d) (1.4% 1m) (38.2% 1y) (0.0% 2d) (0.0% 3d) (0.1% 7d) (Infinity% volume)
Earnings Calendar: 2024-02-22
Market Cap: $ 2,701,955,921
http://www.kratosdefense.com
Sec Filling | Patents | 3000 employees

(US) Kratos Defense & Security Solutions, Inc. provides mission critical products, services and solutions for United States national security priorities. Its products include microwave electronic products, satellite communications, modular systems, and rocket support operating. The company was founded on December 19, 1994 and is headquartered in San Diego, CA.

defense security electronics satellite communication

add to watch list Paper trade email alert is off

LPL Financial Holdings Inc.

LPLA | $262.47 1.04% 1.03% 440K

Finance

(0.0% 1d) (-3.6% 1m) (26.2% 1y) (0.0% 2d) (0.0% 3d) (-1.5% 7d) (-100.0% volume)
Earnings Calendar: 2024-02-01
Market Cap: $ 19,606,700,341
http://www.lpl.com
Sec Filling | Patents | 4343 employees

(US) LPL Financial Holdings, Inc. serves independent financial advisors and financial institutions, providing them with the technology, research, clearing and compliance services, and practice management programs they need to create and grow their practices. It provide objective financial guidance to millions of American families seeking wealth management, retirement planning, financial planning and asset management solutions. The company was founded in 1989 and is headquartered in San Diego, CA.

add to watch list Paper trade email alert is off

Carnival Corporation

CCL | News | $14.12 -0.42% 0.0% 29M

Consumer Services

(0.0% 1d) (-15.8% 1m) (52.0% 1y) (0.0% 2d) (0.0% 3d) (-3.7% 7d) (NaN% volume)
Earnings Calendar: 2024-03-27
Market Cap: $ 15,847,164,246
http://www.carnivalcorp.com
Sec Filling | Patents | 11500 employees

(United States) Carnival Corp. engages in the operation of cruise ships. It operates through the following business segments: North America, Europe, Australia, and Asia (EEA), Cruise Support, and Tour and Other. The North America segment includes Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe, Australia, and Asia (EEA) segment comprises of AIDA, Costa, Cunard, P&O Cruises (Australia), P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

hotel brands

add to watch list Paper trade email alert is off

Natera, Inc.

NTRA S | $85.275 -2.3% -2.35% 2.5M

Health Services

(0.0% 1d) (-2.8% 1m) (66.5% 1y) (0.0% 2d) (0.0% 3d) (-0.1% 7d) (-50.05% volume)
Earnings Calendar: 2024-02-27
Market Cap: $ 10,297,627,961
http://www.natera.com
Sec Filling | Patents | 1039 employees

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The firm also offers Constellation, a cloud-based software product that allows laboratory customers to gain access to the algorithms and bioinformatics in order to validate and launch tests based on the technology. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA.

genetic diagnostics

add to watch list Paper trade email alert is off

Uber Technologies, Inc.

UBER M | $69.2 -2.95% -0.19% 23M

Technology Services

(0.0% 1d) (-8.3% 1m) (129.0% 1y) (0.0% 2d) (-4.1% 3d) (-1.7% 7d) (NaN% volume)
Earnings Calendar:
Market Cap: $ 128,774,698,176
http://www.uber.com
Sec Filling | Patents | 26900 employees

Uber Technologies, Inc. operates as a technology platform for people and things mobility. The firm offers multi-modal people transportation, restaurant food delivery, and connecting freight carriers and shippers. It operates through the following segments: Rides, Eats, Freight, Other Bets and ATG and Other Technology Programs. The Rides segment refers to products that connect consumers with Rides Drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, or taxis. The Eats segment allows consumers to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment leverages proprietary technology, brand awareness, and experience revolutionizing industries to connect carriers with shippers on its platform, and gives carriers upfront, transparent pricing and the ability to book a shipment. The Other Bets segment consists of multiple investment stage offerings. The ATG and Other Technology Programs segment primarily responsible for the development and commercialization of autonomous vehicle and ridesharing technologies, as well as Uber Elevate. The company was founded by Oscar Salazar Gaitan, Travis Kalanick and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

vehicles autonomous restaurant pets food brands msa

add to watch list Paper trade email alert is off

Myriad Genetics, Inc.

MYGN F | $18.515 0.03% 0.03% 490K

Health Technology

(0.0% 1d) (-16.2% 1m) (-14.8% 1y) (0.0% 2d) (0.0% 3d) (-2.8% 7d) (Infinity% volume)
Earnings Calendar: 2024-02-27
Market Cap: $ 1,675,204,891
http://www.myriad.com
Sec Filling | Patents | 2700 employees

(US) Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic test. It operates through the Diagnostics and Other segments. The Diagnostics segment provides testing and collaborative development of testing that is designed to asses an individual's risk of developing a disease later in life. The Other segment offers products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients; and also includes corporate services such as finance, human resources, legal, and information technology. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

molecular diagnostics genetic diagnostics information technology

add to watch list Paper trade email alert is off

FuelCell Energy, Inc.

FCEL A | $0.884 -5.02% -5.28% 29M

Electronic Technology

(0.0% 1d) (-19.1% 1m) (-55.1% 1y) (0.0% 2d) (0.0% 3d) (-8.8% 7d) (610.4% volume)
Earnings Calendar: 2023-12-19
Market Cap: $ 399,446,056
http://www.fuelcellenergy.com
Sec Filling | Patents | 538 employees

(US) FuelCell Energy, Inc. develops environmentally responsible distributed baseload power solutions through proprietary molten-carbonate fuel cell technology. It develops turn-key distributed power generation solutions and provides comprehensive services for the life of the power plant. The firm's fuel cell solution is an alternative to traditional combustion-based power generation and is complementary to an energy mix consisting of intermittent sources of energy, such as solar and wind turbines. It provides solutions for various applications, including utility-scale distributed generation, on-site power generation, combined heat and power, distributed hydrogen, carbon capture and hydrogen-based long duration storage. The Company's platform has the differentiating ability to do all these applications utilizing multiple sources of fuel including natural gas, renewable biogas, propane among others sources. The company was founded in 1969 and is headquartered in Danbury, CT.

hydrogen energy solar natural gas t-cell hepatitis renewable ceiling

add to watch list Paper trade email alert is off

Intel Corporation

INTC | $34.2 -2.4% -2.46% 58M

Electronic Technology

(0.0% 1d) (-16.1% 1m) (14.7% 1y) (0.0% 2d) (-0.8% 3d) (-2.5% 7d) (-100.0% volume)
Earnings Calendar: 2024-01-25
Market Cap: $ 144,597,600,000
http://www.intel.com
Sec Filling | Patents | 110800 employees

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center Group (DCG), Internet of Things Group (IOTG), Non-Volatile Memory Solutions Group (NSG), Programmable Solutions (PSG), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCG segment includes workload-optimized platforms and related products designed for enterprise, cloud, and communication infrastructure market. The IOTG segment offers compute solutions for targeted verticals and embedded applications for the retail, manufacturing, health care, energy, automotive, and government market segments. The NSG segment constitutes of NAND flash memory products primarily used in solid-state drives. The PSG segment contains programmable semiconductors and related products for a broad range of markets, including communications, data center, industrial, military, and automotive. The All Other segment consists of results from other non-reportable segment and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

energy optical computational automotive semiconductor phone communication military

add to watch list Paper trade email alert is off

Carnival Corporation

CUK | News | $12.73 -0.55% -0.47% 1.1M

Consumer Services

(0.0% 1d) (-16.1% 1m) (51.2% 1y) (0.0% 2d) (0.0% 3d) (-2.7% 7d) (NaN% volume)
Earnings Calendar:
Market Cap: $ 1,843,292,505
http://carnivalcorp.com
Sec Filling | Patents | n/a employees

Carnival Plc operates as a global cruise and vacation company. It offers holiday and vacation products to a customer base that is broadly varied in terms of cultures, languages and leisure-time preferences. It operates through the North America, and Europe, Australia and Asia segments. The North America segment includes Carnival Cruise Line, Holland America Line, Princess and Seabourn. The Europe, Australia and Asia segment includes AIDA, Costa, Cunard, P&O Cruises (Australia) and P&O Cruises (UK). The company was founded on July 19, 2000 and is headquartered in London, the United Kingdom.

msa

add to watch list Paper trade email alert is off

AbbVie Inc.

ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

(0.0% 1d) (-7.3% 1m) (2.1% 1y) (0.0% 2d) (0.8% 3d) (2.2% 7d) (NaN% volume)
Earnings Calendar:
Market Cap: $ 294,653,364,441
http://www.abbvie.com
Sec Filling | Patents | 30000 employees

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

cancer hiv autoimmunity hepatitis fibrosis metabolic parkinson neurological

Drugs

Alcohol - Hand Sanitizer (Alcohol)
Androgel (Testosterone)
Creon (Pancrelipase)
Depakote (Divalproex Sodium)
Depakote ER (Divalproex Sodium)
Depakote Sprinkles (Divalproex Sodium)
Duopa (Carbidopa and Levodopa)
Gengraf (Cyclosporine)
Humira (Adalimumab)
Kaletra (Lopinavir and Ritonavir)
K-Tab (Potassium Chloride)
Lupaneta Pack (leuprolide acetate and norethindrone acetate)
Lupron Depot (leuprolide acetate)
Lupron Depot-PED (leuprolide acetate)
Marinol (Dronabinol)
Mavyret (Glecaprevir and Pibrentasvir)
Niaspan (Niacin)
Nimbex (Cisatracurium besylate)
Norvir (Ritonavir)
Oriahnn (Elagolix and Estradiol and Norethisterone)
Orilissa (Elagolix)
Rinvoq (Upadacitinib)
Skyrizi (Risankizumab-rzaa)
Survanta (Beractant)
Synthroid (Levothyroxine Sodium)
Tarka (Trandolapril and Verapamil Hydrochloride)
Tricor (Fenofibrate)
Trilipix (Fenofibric Acid)
Ultane (Sevoflurane)
Venclexta (Venetoclax)
Viekira Pak (Dasabuvir and Ombitasvir and Paritaprevir and Ritonavir)
Zemplar (Paricalcitol)

add to watch list Paper trade email alert is off

KBR, Inc.

KBR A | $62.67 0.87% 0.0% 690K

Technology Services

(0.0% 1d) (3.0% 1m) (8.8% 1y) (0.0% 2d) (0.0% 3d) (0.9% 7d) (Infinity% volume)
Earnings Calendar: 2024-02-20
Market Cap: $ 8,438,581,366
http://www.kbr.com
Sec Filling | Patents | 28000 employees

KBR, Inc. engages in the provision of differentiated professional services and technologies across the asset and program life-cycle within the government services and hydrocarbons industries. It operates through the following segments: Government Solutions, Technology Solutions, Energy Solutions, Non-strategic Business, and Other. The Government Solutions segment provides full life-cycle support solutions to defense, space, aviation, and other programs and missions for military and other government agencies. The Technology Solutions segment combines KBR's proprietary technologies, equipment, and catalyst supply and associated knowledge-based services into a global business for refining, petrochemicals, inorganic, and specialty chemicals as well as gasification, syngas, ammonia, nitric acid, and fertilizers. The Energy Solutions segment provides full life-cycle support solutions across the upstream, midstream and downstream hydrocarbons markets. The Non-strategic Business segment represents the operations or activities which the company intends to exit upon completion of existing contracts. The Other segment includes corporate expenses and general and administrative expenses not allocated to the business segments above. The company was founded on March 21, 2006 and is headquartered in Houston, TX.

energy defense fertilizer military

add to watch list Paper trade email alert is off

Xponential Fitness Inc - Class A

XPOF | $13.15 0.31% 0.0% 540K

(0.0% 1d) (-13.0% 1m) (-59.3% 1y) (0.0% 2d) (0.0% 3d) (-7.6% 7d) (11.42% volume)
Earnings Calendar:
Market Cap: $ 406,217,150
https://www.xponential.com
Sec Filling | Patents | 2021 employees

Founded in 2017 and headquartered in Irvine, California, Xponential Fitness, Inc. is a curator of leading boutique fitness brands across multiple verticals. Through its mission to make boutique fitness accessible to everyone, the Company has built and curated a diversified platform of nine boutique fitness brands spanning across verticals including Pilates, indoor cycling, barre, stretching, rowing, dancing, boxing, running and yoga. In partnership with its franchisees, Xponential Fitness offers energetic, accessible and personalized workout experiences led by highly qualified instructors in studio locations across 48 U.S. states and 10 additional countries as of June 30, 2021.

brands

add to watch list Paper trade email alert is off

XOMA Corporation

XOMA | News | $24.97 1.55% 1.52% 17K

Health Technology

(0.0% 1d) (-1.5% 1m) (29.6% 1y) (0.0% 2d) (0.0% 3d) (-0.4% 7d) (NaN% volume)
Earnings Calendar: 2024-03-07
Market Cap: $ 290,526,325
http://www.xoma.com
Sec Filling | Patents | 10 employees

(US) XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.

antibody

add to watch list Paper trade email alert is off

X Financial

XYF | $3.78 0.0% 5.6K

Finance

(0.0% 1d) (-13.0% 1m) (12.4% 1y) (0.0% 2d) (0.3% 3d) (-4.5% 7d) (-100.0% volume)
Earnings Calendar:
Market Cap: $ 120,519,350
http://www.xiaoyinggroup.com
Sec Filling | Patents | 693 employees

X Financial engages in the development and provision of technology platform for personal finance services. The company was founded by Yue Tang on January 5, 2015 and is headquartered in Shenzhen, China.

china

add to watch list Paper trade email alert is off

Revolution Medicines, Inc.

RVMD S | $34.95 -2.46% -2.52% 1.2M

Health Technology

(0.0% 1d) (18.3% 1m) (50.7% 1y) (0.0% 2d) (0.0% 3d) (3.6% 7d) (-3.25% volume)
Earnings Calendar: 2024-02-26
Market Cap: $ 5,755,915,500
http://www.revmed.com
Sec Filling | Patents | 95 employees

(US) Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

cancer treatment cancer treatments

add to watch list Paper trade email alert is off

LoanDepot Inc - Class A

LDI A | $2.34 0.86% 0.0% 180K

(0.0% 1d) (-8.7% 1m) (36.9% 1y) (0.0% 2d) (0.0% 3d) (-3.8% 7d) (36.4% volume)
Earnings Calendar: 2024-03-12
Market Cap: $ 198,273,917
https://www.loandepot.com/
Sec Filling | Patents | n/a employees

(United States) loanDepot is a contemporary financial services company dedicated to delivering a best-in-class experience to its mortgage purchase and refinance customers. Launched in 2010, loanDepot offers a diversified network of direct-to-consumer, in-market, partnership and wholesale business channels, uniquely positioning it to serve a wide range of customers. Headquartered in Southern California, the company has funded more than $275 billion since its founding and currently ranks as the second largest retail nonbank lender and one of the leading retail mortgage lenders in the United States. Committed to serving the communities in which its customers and team members live and work, loanDepot is a significant donor supporting a variety of local, regional and national philanthropic efforts, most recently donating more than $2.5 million to directly assist COVID-impacted first responders, healthcare workers, individuals and families nationwide. The Company also is a founding sponsor of War Heroes on Water, which supports ongoing therapeutic healing services for combat-wounded veterans.

covid

add to watch list Paper trade email alert is off

Laboratory Corporation of America Holdings

LH M | $201.48 1.02% 0.0% 770K

Health Services

(0.0% 1d) (-4.5% 1m) (-13.6% 1y) (0.0% 2d) (0.0% 3d) (-3.6% 7d) (-1.19% volume)
Earnings Calendar: 2024-02-15
Market Cap: $ 16,949,683,310
http://www.labcorp.com
Sec Filling | Patents | 65000 employees

(US) Laboratory Corp. of America Holdings is a clinical laboratory company. The firm engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the following segments: LabCorp Diagnostics and Covance Drug Development. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment provides drug development solutions to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC.

genomic diagnostics

add to watch list Paper trade email alert is off

Medtronic plc

MDT | $79.48 0.37% -0.29% 6.7M

Health Technology

(0.0% 1d) (-5.9% 1m) (-5.3% 1y) (0.0% 2d) (0.0% 3d) (-2.4% 7d) (Infinity% volume)
Earnings Calendar: 2024-02-20
Market Cap: $ 105,535,335,400
http://www.medtronic.com
Sec Filling | Patents | 90000 employees

(US) Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.

respiratory heart gastrointestinal diabetes diabetic renal

add to watch list Paper trade email alert is off

Black Diamond Therapeutics, Inc.

BDTX | $5.26 -0.76% -0.76% 390K

Health Technology

(0.0% 1d) (15.7% 1m) (247.1% 1y) (0.0% 2d) (0.0% 3d) (3.1% 7d) (-15.67% volume)
Earnings Calendar: 2024-03-07
Market Cap: $ 272,035,886
http://www.blackdiamondtherapeutics.com
Sec Filling | Patents | 32 employees

Black Diamond Therapeutics, Inc. engages in the biotechnology company that discovers and develops therapeutic agents to target unique oncogenic protein-isoforms. The company was founded by Dr. David M. Epstein and Dr. Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.

add to watch list Paper trade email alert is off